February 28, 2020

February 28, 2020

Criminal Investigations into Chinese Recruitment of Professors and Researchers: The "Thousand Talents" Program

JD Supra – Feb. 27

To be clear, there is nothing illegal per se about research coordination with other countries, but it is easy for institutions and researchers to make mistakes relating to disclosure obligations, as occurred in the case of the Moffitt Cancer Research Center in Tampa, discussed below.

 

China is poaching U.S. medical research from labs and hospitals | Opinion

Lehigh Valley Express Times – Feb. 27

Arguably the most significant investigation came last month at the Moffitt Cancer Center in Tampa, Florida. Two Moffitt executives and four researchers resigned over “compliance violations” that linked them to China’s “Thousand Talents” program.  Also posted to the Patriot-News.

 

Chinese scientist Hongjin Tan gets two-year prison sentence for stealing trade secrets from US energy company

South China Morning Post – Feb. 27

And the Moffitt Cancer Centre in Tampa, Florida, recently reported that six of its employees, including the chief executive, resigned over failing to disclose their connection to the Chinese talent programme.

 

Gold rush: Claiming a stake in Pasco's growing health care scene

Tampa Bay Business Journal – Feb. 27

Today, the county has nursing facilities, outpatient centers and new investments drawing large businesses such as Moffitt Cancer Center and TLC Management’s Blue Heron skilled nursing project. 

 

Study links breast cancer and hair dye

WTSP – Feb. 27

We talked with Dr. Shelley Tworoger from Moffitt Cancer Center about the risk. "There are a lot of chemicals in hair dyes and hair straighteners effects. Some of them have over 5,000 chemicals…”

 

Impact of TP53 Mutation Clearance Prior to Allo-SCT

MedPage Today – Feb. 27

t the recent 2019 American Society of Hematology annual meeting, there were a number of presentations on targeted mutations, and one study out of Moffitt Cancer Center in Tampa, Florida, looked at the controversy regarding the influence of TP53 mutation on allogeneic stem cell transplantation outcomes.

 

Dr. Kuykendall on the Approval of Fedratinib in Myelofibrosis

OncLive – Feb. 25

Andrew T. Kuykendall, MD, assistant member, Department of Malignant Hematology, Moffitt Cancer Center, discusses the addition of fedratinib (Inrebic) to the treatment paradigm in myelofibrosis.

 

SELLAS Announces Positive Follow-Up Phase 1/2 Clinical Data for Galinpepimut-S (GPS) in Acute Myeloid Leukemia (AML)

Globe Newswire – Feb. 26

“These follow-up data build upon the initially published clinical results from the Phase 1/2 study of GPS in AML patients in CR2 and provide further evidence that this novel immunotherapeutic vaccine approach may improve outcomes for patients in this setting, who often harbor measurable residual disease and have a poor prognosis if they are unable to undergo allotransplant,” said Javier Pinilla-Ibarz, MD, PhD, Director of Immunotherapy for Malignant Hematology at the H. Lee Moffitt Cancer Center, and principal investigator of the Phase 1/2 study.

 

First look: New 25K SF cancer research and treatment facility debuts

Orlando Business Journal – Feb. 26

For example, Altamonte Springs-based health care provider and Tampa-based Moffitt Cancer Center announced last September they will establish a clinical research facility and chemotherapy/immunotherapy infusion program at AdventHealth Celebration. 

 

Delayed Cancer Diagnosis Lands $12.5M Verdict in Macon After Repeated Attempts to Settle

Law.com – Feb. 25

The key defense expert was radiation oncologist Jimmy Caudell of the H. Lee Moffitt Cancer Center in Tampa, Florida, Lasky said. 

 

Moffitt committee votes on $340 million hospital expansion

Tampa Bay Business Journal – Feb. 24

Despite being under investigation for its ties with China, Tampa's H. Lee Moffitt Cancer Center and Research Institute continues to pursue a major hospital expansion.

 

State Panel to Investigate Chinese ‘Meddling’ at State-Funded Research Facilities

Spectrum News 13 – Feb. 25

Members will hear from security experts about the information sharing scandal that led to the firing of Moffitt Cancer Center's President & CEO and Director back in December.

 

Dr. Wenham on Trials Evaluating IP, IV, and Dose-Dense Chemotherapy in Ovarian Cancer

OncLive –Feb. 25

Robert M. Wenham, MD, gynecologic oncologist and chair of the Gynecologic Oncology Program at Moffitt Cancer Center, discusses data with intraperitoneal (IP) chemotherapy, dose-dense chemotherapy, and intravenous (IV) chemotherapy in patients with advanced ovarian cancer.

 

Dr. Hoffman on Research Regarding Neoadjuvant Chemo and Primary Debulking in Ovarian Cancer

OncLive – Feb. 25

Mitchel Hoffman, MD, gynecologic oncologist, Moffitt Cancer Center, discusses ongoing research regarding neoadjuvant chemotherapy and primary debulking surgery in advanced ovarian cancer.

 

Tampa company that developed cancer vaccine expanding human clinical trials

KTVX – Feb. 25

The clinical trial will span over five different sites, including the Tampa Bay area location that opened at Moffitt Cancer Center two weeks ago.  Also shared on KRQE, WTNH, WSPA, KRBC, WJET, WTAJ, KMID, WWLP, WVLA, WRBL, KLFY, WSAV, WCBD, WTEN, WCMH and WRIC.

 

NWA convention draws record crowd, crowns Texan as Watermelon Queen

The Packer – Feb. 25

Beside raising over $350,000 for the association, the annual auction at the convention raised money for charities, including $100,000 for Warriors for Freedom, a group dedicated to help military veterans. The group also donated $45,0000 to the Moffitt Cancer Center in Tampa, Fla.

 

Oncologie, Inc. Announces Collaboration with Moffitt Cancer Center to Advance the Development of Precision Medicine for the Treatment of Gastric and Gastrointestinal Cancers

PR Newswire – Feb. 25

Oncologie, Inc., a clinical-stage biopharmaceutical company developing innovative oncology treatments targeting the tumor microenvironment (TME), announced today that it has entered into a collaboration agreement with Moffitt Cancer Center.

 

Moffitt closes on $23.5M Pasco land deal for research hub

Tampa Bay Business Journal – Feb. 25

Tampa's Moffitt Cancer Center now has a footprint in Pasco County after purchasing 775 acres.

 

Moffitt Cancer Center buys 775 acres in Pasco

Tampa Bay Times – Feb. 24

  1. Lee Moffitt Cancer Center and Research Institute’s planned expansion into Pasco County officially has a place to call home. The center paid $23.5 million for 775 acres of one-time ranch land that Lennar is developing into the massive Angeline residential and commercial project.

 

Region in Focus: Tracking the Growth across Six Regions in the U.S. Southeast

Urban Land – Feb. 24

“The H. Lee Moffitt Cancer Center & Research Institute—a nonprofit cancer treatment and research center—and AdventHealth are working to open an outpatient cancer center on the campus of AdventHealth Wesley Chapel in Pasco County,” she adds. “The outpatient center is expected to open in the fall of 2020.”

 

New leaders at SKCC, Mount Sinai, NHF

MD Edge – Feb. 24

Dr. Gergis earned his medical degree from Cairo (Egypt) University. He completed an internal medicine residency and a hematology/oncology fellowship at the Brooklyn Hospital of Weill Cornell. He also completed a bone marrow transplant fellowship at the Moffitt Cancer Center in Tampa.

 

Universities with conflicts?

WFLA – Feb. 23

Following the firing of 6 cancer researchers at Moffitt Cancer Center in December for failing to disclose their ties to china the state house set up a select investigative committee that led to questions about universities that may have conflicts as capitol bureau reporter Mike Vasilinda tells us the committee was told this week that most institutions rely on self-reporting.

 

New VTE incidence ‘significant’ after CAR T-cell therapy for lymphoma

Healio – Feb. 23

“Given the numbers of patients who develop a new clot after infusion, it is important to investigate this further,” Hamza Hashmi, MD, clinical fellow in the blood and marrow transplant and cellular immunotherapy program at Moffitt Cancer Center, told Healio.

 

Olympic figure skater raises money for cancer research

WKRN - Feb. 23

Scott Hamilton is donating the proceeds of his new children’s book and a portion of the ticket sales from his reading to the Scott Hamilton Cares Foundation and Moffitt Cancer Center. 

 

Florida Cancer Specialists to move out of New Port Richey offices, build new center in Trinity

Tampa Bay Business Journal – Feb. 21

Cancer services is a growing field in Pasco County, as Moffitt Cancer Center also plans to occupy space at the AdventHealth Wesley Chapel campus. Moffitt will occupy a third of the space inside a new second medical building being constructed on the Wesley Chapel campus, which is estimated to be a $44 million project. 

 

Tampa could be at the center of finding a cure for cancer

WTSP – Feb. 21

The location for the human trial in Tampa opened at Moffitt Cancer Center a couple of weeks ago, and four more sites will be spread across the country.

 

Virus del Papiloma y Sida

WAPA – Feb. 21

 

Aumentan casos de cáncer de orofaringe entre hombres

Telemundo – Feb. 21

 

Ciencias Medicas realizará el estudio: Prevención de VPH Oral en Hombres viviendo con VIH

Notiséis 360 PR – Feb. 21

 

Business People Feb. 24

Sarasota Herald Tribune – Feb. 24

He earned his medical degree from Ross University School of Medicine on Dominica, West Indies. He completed his internal medicine residency at Case Medical Center in Cleveland, Ohio, and gastroenterology fellowship at the University of South Florida in Tampa. Kucera is also fellowship trained in interventional endoscopy and endoscopic oncology from Moffitt Cancer Center in Tampa.

 

###

Please note we cannot guarantee the accuracy or availability of links. The stories belong to the respective publishers, and links may expire. Some news sites require you to register and select a password in order to retrieve articles, but most usually do not charge a fee to retrieve these news stories.